For example, in AD current FDA- approved treatments are acetylcholine esterase (AChE) inhibitors, N-methyl-D-aspartate (NMDA) antagonists, orexin receptor antagonists, and Aβ monoclonal antibodies [7,8]. This evidence concerns the gene ACHE and Alzheimer disease.